Skip to content

Long term and clinical impact of the Lifestyle Management for Arthritis Programme (LMAP) for people with inflammatory arthritis

Long term and clinical impact of the Lifestyle Management for Arthritis Programme (LMAP) for people with inflammatory arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN61657013
Enrollment
293
Registered
2010-03-31
Start date
2008-03-17
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Musculoskeletal

Interventions

Study 1: a long-term (6y) follow up of a previous clinical trial. Patients were randomised to receive the LMAP education programme or a standard arthritis education programme. The LMAP consists of 9 x

Sponsors

Royal Derby Hospital (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Study 1: Past participants of RCT evaluating the LMAP. Study 2: 1. Patients aged over 18 years 2. Diagnosis of either rheumatoid arthritis, inflammatory arthritis or psoriatic arthritis, confirmed by a consultant rheumatologist 3. Referred by a member of the rheumatology multi-disciplinary team as suitable for the education programme

Exclusion criteria

Exclusion criteria: Study 1: Past participants considered no longer well enough to participate by their Consultant. Study 2: Does not meet inclusion criteria

Design outcomes

Primary

MeasureTime frame
Pain using a 10 cm visual analgue scale (0 = no pain; 10 = pain as bad as it can be). Study 1: 6 years

Secondary

MeasureTime frame
Study 1: All measurements at 6 year follow-up Study 2: all measurements at 0, 6 and 12 months

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026